Global Obesity Surgery Devices Market is

Global Obesity
Surgery Devices Market is Estimated to Reach $41 Billion by 2024

Global
obesity surgery devices market report published by
Accurize Market Research forecast that the global market is expected to reach
$41 billion by 2024; growing at a CAGR of 9.2% from 2017 to 2025. By geography,
the Asia Pacific and North America are expected to grow at a CAGR of XX% and XX%,
respectively, during the forecast period.

Request Sample:

https://www.accurizemarketresearch.com/report/obesity-surgery-devices-market/sample-request

Growth in disposable
income of consumers and increasing uptake of fast-food global drives the growth
of the market

The upsurge in disposable
income, increasing uptake of fast food, global obesity endemic, and the growing
prevalence of childhood obesity fuels the demand for the global obesity surgery
devices market. Moreover, rising awareness among overweight people in developed
regions about various ill effects of obesity also boosts the growth of the
market.

Market Segmentation

The global obesity surgery
devices market has been bifurcated on the basis of procedure, devices, and
geography. The market is segmented by a procedure as Roux-en-Y gastric bypass,
sleeve gastrostomy, adjustable gastric banding, biliopancreatic diversion with
a duodenal switch, and others. Furthermore, the devices segment is bifurcated
as staples, gastric bands, gastric electrical stimulator, intragastric balloon,
and others.

By geography, the market is
segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW).
North America is further bifurcated in the U.S., Canada, and Mexico whereas
Europe segment consists of the UK, Russia, Germany, France, Italy, and others.
Asia-Pacific is segmented into India, China, Japan, South Korea, and others
while RoW is bifurcated into South America, the Middle East, and Africa.

Customize Report:

https://www.accurizemarketresearch.com/report/obesity-surgery-devices-market/ask-for-customization

“Roux-en-Y gastric
bypass accounted for the largest market share in the procedure segment",
says Accurize

By procedure segment,
Roux-en-Y gastric bypass held the largest market share, whereas sleeve
gastrostomy dominated with fastest CAGR.

“North America
dominated the global market with the highest market share over the forecast
period", says Accurize

In 2017, North America
accounted for the major market share of 67.1% in 2017, followed by Europe with
19.2%. In terms of growth, Asia-Pacific is expected to attain the fastest CAGR,
driven by high consumption of fast food, the growing popularity of medical
tourism, and improved healthcare infrastructure.

Top players in the
market

The key market players
include TransEnterix Inc., Medtronic Inc., EnteroMedics Inc., Allergan Inc.,
Johnson and Johnson, Aspire Bariatrics, Inc., Spatz FGIA Inc., Cousin Biotech,
Mediflex Surgical Products, and IntraPace Inc.among others.